Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06110520 · ClinicalTrials.gov registry record · NA
Violet Light for the Suppression of Myopia
A NA study of Myopia and Phototherapy, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT06110520: Recruiting NA study of Myopia and Phototherapy, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT06110520 is a NA study of Myopia and Phototherapy that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 72 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06110520, a NA study of Myopia and Phototherapy, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
The study explores the suppression of myopia via violet light.
Primary Outcome
Measurement of the distance between anterior cornea and retina via IOL Master in millimeters.
Conditions Studied
Interventions
- DEVICE Violet Light Lamp
- DEVICE White Light Lamp
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2023-06-07 |
| Est. Completion | 2028-01-01 |
| Phase | NA |
What NCT06110520 shows while recruiting
NCT06110520 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (73% lower).
The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Violet Light Lamp is the first listed.
NCT06110520 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06110520 about?
NCT06110520 is a clinical study titled "Violet Light for the Suppression of Myopia". The study explores the suppression of myopia via violet light.
What is the current status of trial NCT06110520?
This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2023-06-07. Estimated completion is 2028-01-01.
What conditions does trial NCT06110520 study?
This clinical trial studies the following conditions: Myopia, Phototherapy.
What interventions are being tested in trial NCT06110520?
The interventions under investigation include: Violet Light Lamp (DEVICE), White Light Lamp (DEVICE).
Who is sponsoring clinical trial NCT06110520?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06110520 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06110520's enrollment target sits among peer trials
72 50th of 90 higher than 41 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI